Impel NeuroPharma's Unattributed - II Round

Impel NeuroPharma raised a round of funding on September 14, 2015.

Impel is committed to improving the delivery of CNS therapeutics and is rapidly growing its pipeline of internal products through its INP-101, INP-102 and INP-104 programs. The Company's INP-104 produ…

Articles about Impel NeuroPharma's Unattributed - II Round: